Artificial intelligence advancements in monoclonal antibody development technology.

Front Immunol · 2026 · PMC13347191 · PMID 42427491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an important trendno p-value reported

Modern approaches illustrate an important trend toward integrated design and enhancement strategies that simultaneously optimize affinity, stability, and immunogenicity risk preserving developability attributes.

also in 625 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.